A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor

NCT00028067 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Atazanavir
DRUG: Nelfinavir mesylate

Sponsor

Bristol-Myers Squibb